52940-12-2 Usage
Uses
Used in Pharmaceutical Industry:
1,3,6,8-tetrahydroxyanthracene-9,10-dione is used as a pharmaceutical compound for its potential therapeutic applications. Its unique structure and properties may contribute to the development of new drugs targeting various diseases and conditions.
Used in Chemical Research:
1,3,6,8-tetrahydroxyanthracene-9,10-dione is used as a research compound in the field of chemistry. Its unique structure and properties make it an interesting subject for studying chemical reactions, mechanisms, and potential applications in various chemical processes.
Used in Material Science:
1,3,6,8-tetrahydroxyanthracene-9,10-dione may be used as a component in the development of new materials with specific properties. Its unique structure and functional groups can be exploited to create materials with tailored characteristics for various applications.
Used in Environmental Applications:
1,3,6,8-tetrahydroxyanthracene-9,10-dione may have potential applications in environmental science, such as in the remediation of contaminated sites or the development of eco-friendly materials. Its unique properties could be harnessed to address environmental challenges and promote sustainability.
Check Digit Verification of cas no
The CAS Registry Mumber 52940-12-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,9,4 and 0 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 52940-12:
(7*5)+(6*2)+(5*9)+(4*4)+(3*0)+(2*1)+(1*2)=112
112 % 10 = 2
So 52940-12-2 is a valid CAS Registry Number.
InChI:InChI=1/C14H8O6/c15-5-1-7-11(9(17)3-5)14(20)12-8(13(7)19)2-6(16)4-10(12)18/h1-4,15-18H
52940-12-2Relevant academic research and scientific papers
A biocatalytic approach towards the preparation of natural deoxyanthraquinones and their impact on cellular viability
Das, Kiran,De, Arijit,Husain, Syed Masood,Maity, Biswanath,Mondal, Amit,Rajput, Anshul
supporting information, p. 3087 - 3090 (2022/02/21)
Herein, a two-step chemoenzymatic process for the synthesis of medicinally important 3-deoxygenated anthra-9,10-quinones is developed. It involves a regio- and stereoselective reduction of hydroanthraquinones to (R)-configured dihydroanthracenones using an anthrol reductase of T. islandicus, followed by oxidation and dehydration to obtain deoxyanthraquinones in 65-80% yield. Comparison of the cell viability of normal human kidney HEK293 cells between anthraquinones and their deoxy derivatives revealed less toxicity for the latter.
Identification and characterization of an anthrol reductase from: Talaromyces islandicus (Penicillium islandicum) WF-38-12
Singh, Shailesh Kumar,Mondal, Amit,Saha, Nirmal,Husain, Syed Masood
supporting information, p. 6594 - 6599 (2019/12/26)
An NADPH-dependent oxidoreductase from Talaromyces islandicus WF-38-12 has been identified through genome analysis. It has been shown to catalyze a regio- and stereoselective reduction of anthrols (formed in situ by the reduction of anthraquinones in the presence of Na2S2O4) to (R)-dihydroanthracenones, with high enantiomeric excess (>99%). The implications of results on the biosynthesis of deoxygenated (bis)anthraquinones and modified (bis)anthraquinones are discussed.
